MB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status | Clinical infectious diseases |  | 2023 | 169 | 186 | ||
| SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of october 2020 to february 2021-implementation of swiss-wide diagnostic screening and whole genome sequencing | Microorganisms | | 2021 | 240 | 222 | ||
| Toscana virus meningitis case in Switzerland: an example of the ezVIR bioinformatics pipeline utility for the identification of emerging viruses | Clinical microbiology and infection | | 2015 | 753 | 256 | ||
| Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn | The Pediatric infectious disease journal |  | 2013 | 726 | 3 | ||
| Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine | Antiviral therapy | | 2012 | 652 | 6 | ||
| Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine | PloS one | | 2012 | 773 | 341 | ||
| Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | | 2012 | 724 | 0 | ||
| A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | | 2012 | 693 | 0 | ||
| Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac disease | Journal of pediatric gastroenterology and nutrition | | 2012 | 636 | 461 | ||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | 2011 | 1,052 | 618 | ||
| Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children | Vaccine | | 2011 | 647 | 0 | ||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | 2011 | 878 | 8 |
